• Users Online: 309
  • Print this page
  • Email this page
This article has been cited by
1Metastatic smooth muscle tumor of uncertain malignant potential after laparoscopic presuming myomectomy
Marisa Tossamartvorakul,MarieChristine Valerie R. Mendoza,Kuan-Gen Huang,Shu-Han Chang
Gynecology and Minimally Invasive Therapy.2021;10(3)187
[DOI]
2What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of "real-world" data
Neha Shah,Elizabeth Egbase,Michael Sideris,Funlayo Odejinmi
Archives of Gynecology and Obstetrics.2021;303(5)1121
[DOI]
3Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment
A. V. Kozachenko,Z. V. Revazova,L. V. Adamyan,T. A. Demura,N. V. Zaytsev
Medical Council.2019;303(13)29
[DOI]
4Ulipristalacetat – aktueller Stellenwert in der Myombehandlung
Thomas Römer
Gynäkologische Endokrinologie.2020;18(1)35
[DOI]
5Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study
Pasquale De Franciscis,Antonio Schiattarella,Gaetano Riemma,Domenico Labriola,Domenico Ambrosio,Salvatore Giovanni Vitale,Antonio Cianci,Gaspare Cucinella,Gloria Calagna,Nicola Colacurci
Minimally Invasive Therapy & Allied Technologies.2022;31(3)435
[DOI]
6Unusual Leiomyoma Presentations and Management
Pratima Mittal,Rekha Bharti,Jyotsna Suri,Divya Pandey,Sumitra Bachani,Zeba Khanam
Journal of South Asian Federation of Obstetrics and Gynaecology.2022;14(3)227
[DOI]